Share of pregnant women with HIV that receive antiretroviral therapy in Cameroon
Cameroon: Share of pregnant women with HIV that receive antiretroviral therapy was 59.0% in 2024. ◆ Volatile
Share of pregnant women with HIV that receive antiretroviral therapy in Cameroon, 2000–2024
Source: UNAIDS estimates, via World Bank (2026) – processed by Our World in Data. Measured in % of pregnant women living with HIV.
Analysis
The most recent figure for share of pregnant women with hiv that receive antiretroviral therapy in Cameroon is 59.0%, measured in 2024.
Compared with earlier readings it is down 18.1% on the previous year and down 32.2% over ten years.
Over the whole period, share of pregnant women with hiv that receive antiretroviral therapy in Cameroon peaked at 97.0% in 2017 and was at its lowest, 0.0%, in 2000.
Cameroon ranks 62nd of 84 countries on this measure, in the middle of the range.
The series is highly variable year to year, so single readings are best treated with caution.
Share of pregnant women with HIV that receive antiretroviral therapy in Cameroon, year by year
| Year | % of pregnant women living with HIV | Change |
|---|---|---|
| 2000 | 0.0% | — |
| 2001 | 0.0% | — |
| 2002 | 4.0% | — |
| 2003 | 8.0% | +100.0% |
| 2004 | 13.0% | +62.5% |
| 2005 | 11.0% | -15.4% |
| 2006 | 24.0% | +118.2% |
| 2007 | 24.0% | +0.0% |
| 2008 | 33.0% | +37.5% |
| 2009 | 30.0% | -9.1% |
| 2010 | 47.0% | +56.7% |
| 2011 | 55.0% | +17.0% |
| 2012 | 65.0% | +18.2% |
| 2013 | 88.0% | +35.4% |
| 2014 | 87.0% | -1.1% |
| 2015 | 91.0% | +4.6% |
| 2016 | 94.0% | +3.3% |
| 2017 | 97.0% | +3.2% |
| 2018 | 95.0% | -2.1% |
| 2019 | 77.0% | -18.9% |
| 2020 | 77.0% | +0.0% |
| 2021 | 83.0% | +7.8% |
| 2022 | 79.0% | -4.8% |
| 2023 | 72.0% | -8.9% |
| 2024 | 59.0% | -18.1% |
Cameroon compared with similar countries
- Cameroon's 59.0% is below the median for lower middle income countries, which is 83.5%, 71% of the median. (32 countries reporting)
- Cameroon's 59.0% is below the median for Sub-Saharan Africa, which is 82.0%, 72% of the median. (41 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 14.7% | 0.0% | 33.0% | 10 |
| 2010s | 79.6% | 47.0% | 97.0% | 10 |
| 2020s | 74.0% | 59.0% | 83.0% | 5 |
Countries ranked near Cameroon
More gender data for Cameroon
- Child population (UN estimates and projections) 13,337 (2030)
- Child population (UN estimates and projections) (0-14), annual growth 1.53 % change on previous year (2030)
- Population 20,440 (2030)
- Working-age population (UN estimates and projections) 20,440 (2030)
- Population (UN estimates and projections), annual growth rate 3.01 % change on previous year (2030)
- Age population, age 00, female, interpolated 465,137 (2025)
- Age population, age 00, male, interpolated 475,018 (2025)
- Age population, age 01, female, interpolated 453,098 (2025)
- Age population, age 01, male, interpolated 461,925 (2025)
- Age population, age 02, female, interpolated 443,236 (2025)
Frequently asked questions
- What is share of pregnant women with hiv that receive antiretroviral therapy in Cameroon?
- Share of pregnant women with hiv that receive antiretroviral therapy in Cameroon was 59.0% in 2024, according to UNAIDS estimates, via World Bank (2026) – processed by Our World in Data.
- What is the highest share of pregnant women with hiv that receive antiretroviral therapy recorded in Cameroon?
- The highest recorded value was 97.0% in 2017.
- What is the lowest share of pregnant women with hiv that receive antiretroviral therapy recorded in Cameroon?
- The lowest recorded value was 0.0% in 2000.
- How does Cameroon rank for share of pregnant women with hiv that receive antiretroviral therapy?
- Cameroon ranks 62nd out of 84 countries with data for 2024.
- Is share of pregnant women with hiv that receive antiretroviral therapy rising or falling in Cameroon?
- Over the last ten years it is down 32.2%. The long-run trend across the full record is volatile.
- Where does this Cameroon data come from?
- The figures come from UNAIDS estimates, via World Bank (2026) – processed by Our World in Data, published as part of Share of pregnant women with HIV that receive antiretroviral therapy. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (Our World in Data).
About this data
Antiretroviral medicine is used to prevent mother-to-child transmission of HIV.